The inhibition of HIF-1a degradation by dimethyloxalylglycine (DMOG) has been shown to activate CHK1 and to sensitize melanoma cells to the CHK1/2 inhibitor AZD7762 in vitro [70]. The gene discussed is CHEK1; the disease is melanoma.